BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9437064)

  • 1. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl.
    Ko S; Lee T; Ng S; Lin J; Cheng Y
    Abdom Imaging; 1998; 23(1):56-9. PubMed ID: 9437064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of nodular liver lesions in Wilson's disease.
    Kozic D; Svetel M; Petrovic I; Sener RN; Kostic VS
    Acta Radiol; 2006 Sep; 47(7):624-7. PubMed ID: 16950693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late presentation of Wilson's disease].
    Santander Vaquero C
    Rev Esp Enferm Dig; 2002 Aug; 94(8):502-3. PubMed ID: 12486857
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's Disease: A Review for the General Pediatrician.
    Capone K; Azzam RK
    Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wilson's disease].
    Günther P; Hermann W; Kühn HJ; Wagner A
    Ther Umsch; 2007 Jan; 64(1):57-61. PubMed ID: 17221826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
    Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
    Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's disease: clinical, genetic and pharmacological findings.
    Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
    Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
    El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
    Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease.
    Alanen A; Komu M; Penttinen M; Leino R
    Br J Radiol; 1999 Aug; 72(860):749-56. PubMed ID: 10624340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
    Dzieżyc K; Litwin T; Chabik G; Członkowska A
    Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some therapeutic observations in Wilson's disease.
    Shoulson I; Goldblatt D; Plassche W; Wilson G
    Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.